Chanhen(SZ:002895) EBSCN·2025-08-27 10:02Investment Rating - The report maintains a "Buy" rating for the company [5] Core Views - The company achieved significant revenue growth in its phosphate chemical products, with a 35.28% year-on-year increase in revenue to 3.36 billion yuan in the first half of 2025 [1] - The company plans to distribute a cash dividend of 3 yuan per 10 shares, totaling 182 million yuan, reflecting a payout ratio of 34.0% [3] - The company has a strong phosphate resource advantage, with total phosphate reserves exceeding 580 million tons and an annual production capacity of over 3.2 million tons [3] - The company’s subsidiary in Guangxi achieved a revenue of 1.285 billion yuan, a year-on-year increase of 70.9%, and significantly reduced its net loss by 47.5% [2] Summary by Sections Financial Performance - In the first half of 2025, the company reported a revenue of 3.36 billion yuan, a 35.28% increase year-on-year, and a net profit of 536 million yuan, up 51.54% [1] - The second quarter of 2025 saw a revenue of 1.867 billion yuan, a 29.63% year-on-year increase, and a net profit of 334 million yuan, reflecting a 52.48% increase [1] Product Performance - Key products such as feed-grade dicalcium phosphate, monoammonium phosphate, and phosphoric acid saw revenue increases of 33.2%, 38.9%, and 27.7% respectively in the first half of 2025 [2] - The company’s iron phosphate business achieved a revenue of 318 million yuan, a substantial increase of 104% year-on-year [2] Dividend Policy - The company has consistently maintained a high cash dividend payout, with cumulative cash dividends of 1.55 billion yuan from 2022 to 2024, resulting in a payout ratio of 62.4% [3] Profit Forecast and Valuation - The company’s projected net profits for 2025, 2026, and 2027 are 1.289 billion yuan, 1.573 billion yuan, and 1.847 billion yuan respectively, with a maintained "Buy" rating [3][4]